Susanne Hausmann

Susanne Hausmann is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of 3 patents to her name, her work has the potential to impact medical treatments significantly.

Latest Patents

One of her latest patents is focused on a cross-species-specific PSMAxCD3 bispecific single chain antibody. This invention relates to a bispecific single chain antibody molecule that includes a first binding domain capable of binding to an epitope of the human and non-chimpanzee primate CD3 epsilon chain. The epitope is part of an amino acid sequence comprised in the group consisting of SEQ ID NOs. 2, 4, 6, and 8. Additionally, it features a second binding domain that can bind to prostate-specific membrane antigen (PSMA). The invention also encompasses nucleic acids encoding this bispecific single chain antibody molecule, as well as vectors, host cells, and a process for its production. Furthermore, it relates to pharmaceutical compositions that include this bispecific single chain antibody molecule and its medical uses.

Career Highlights

Susanne has worked with notable companies in the biotechnology sector, including Amgen Research GmbH and Amgen Research (Munich) GmbH. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in antibody development.

Collaborations

Some of her coworkers include Peter Kufer and Matthias Klinger, who have collaborated with her on various projects in the field of biotechnology.

Conclusion

Susanne Hausmann is a trailblazer in the development of bispecific antibodies, with her innovative work poised to advance medical treatments. Her contributions to the field are noteworthy and reflect her dedication to scientific progress.

This text is generated by artificial intelligence and may not be accurate.